APA (7th ed.) Citation

M, K., A, K., D, S., L, X., E, R., A, B., . . . K, S. (2026). BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia. British journal of haematology. https://doi.org/10.1111/bjh.70598

Chicago Style (17th ed.) Citation

M, Karsa, et al. "BCL-2 and MCL1 Co-inhibition Enhances Glucocorticoid Therapy in Preclinical Models of Infant KMT2A-rearranged Acute Lymphoblastic Leukaemia." British Journal of Haematology 2026. https://doi.org/10.1111/bjh.70598.

MLA (9th ed.) Citation

M, Karsa, et al. "BCL-2 and MCL1 Co-inhibition Enhances Glucocorticoid Therapy in Preclinical Models of Infant KMT2A-rearranged Acute Lymphoblastic Leukaemia." British Journal of Haematology, 2026, https://doi.org/10.1111/bjh.70598.